| 宋子平,张瑞珺,康玉英.胆碱能性荨麻疹的发病机制和治疗的研究进展[J].安徽医药,2026,30(9):1726-1730. |
| 胆碱能性荨麻疹的发病机制和治疗的研究进展 |
| Advances in the pathogenesis and treatment of cholinergic urticaria |
| |
| DOI：10.3969/j.issn.1009-6469.2026.09.006 |
| 中文关键词: 胆碱能性荨麻疹 治疗 发病机制 慢性诱导性荨麻疹 奥马珠单抗 |
| 英文关键词: Cholinergic urticaria Treatment Pathogenesis Chronic inducible urticaria Omalizumab |
| 基金项目:山西省卫生计生委科研课题项目( 2018018) |
|
| 摘要点击次数: 322 |
| 全文下载次数: 47 |
| 中文摘要: |
| 胆碱能性荨麻疹( CholU)是一种慢性诱导性荨麻疹，对病人生活质量造成显著影响，且常规治疗往往无法完全控制症状。该研究综述了 CholU的发病机制和治疗的研究进展，重点探讨了基于 CholU不同亚型的分类诊疗原则，也对最新的生物制剂开发与应用进行了介绍。 |
| 英文摘要: |
| Cholinergic urticaria (CholU) is a type of chronic inducible urticaria that significantly affects patients' quality of life, withconventional treatments often failing to fully control symptoms. This review summarizes the research progress on the pathogenesis andtreatment of CholU, with a particular focus on subtype-based diagnostic and therapeutic principles for different CholU subtypes. It alsointroduces the latest developments and applications of biologic agents are also discussed. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
